A second blood test shows promise for the detection of colon cancer, according to a new study. The first, called Shield, was approved by the Food and Drug Administration in July for people 45 and ...

New findings suggest blood tests still being assessed are showing promising results for early cancer screenings, especially ...

The MCED test shows similar performance in cancer survivors and the general population, with a PPV of 50% and high ...

Early detection of lung cancer remains challenging because cancer cells circulating in the blood are extremely rare ( ref1 ). A new research study now shows that a single lung cancer cell can be ...

The blood test also had a sensitivity and specificity of 92.3% and 92.6% for participants who do not have breast cancer. The results were consistent for women with dense breast tissue and non-dense ...

An investigational blood test for early detection of colorectal cancer (CRC) in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC study, the largest study ...

Known as Breast Circulating Methylation Assay (BCMA), the new blood test looks for tumour DNA released into the bloodstream ...

A UK research team has developed a pioneering blood test that could change the way lung cancer is detected and monitored.

When you breathe out, you’re not just releasing carbon dioxide. Your breath carries a complex mix of volatile organic compounds, or VOCs—tiny molecules that come from normal body processes. These ...

These markers are most helpful when someone already has a diagnosed cancer — to track treatment response or detect recurrence ...

Blood tests that promise to spot cancer before symptoms appear are racing toward clinics, pitched as a simple vial of blood ...

A new bipartisan bill would end the coverage gap for dementia screening, allowing early diagnosis when treatments are most ...